Search

everythinglearnresearchcommunity

for

Search:↓

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Hydroxychloroquine may help treat alopecia areata in children.

Male gender and family history predict alopecia areata recurrence.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Children with alopecia areata often experience more anxiety and depression, linked to neglectful family dynamics.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

A machine learning model can predict alopecia areata early using specific gene markers.

Oxidative stress may play a role in alopecia areata, but depression and suicide risk are similar to healthy peers.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Trichoscopy is a useful tool for diagnosing and managing hair and scalp conditions, often better than traditional methods.

Trichoscopy is a useful tool for diagnosing different hair and scalp diseases without surgery.

Trichoscopy is a valuable tool for diagnosing and managing hair and scalp disorders.

Trichoscopy helps diagnose and track alopecia areata by examining specific hair and scalp markers.

Trichoscopy is a quick, cost-effective tool for diagnosing different hair loss conditions.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.